ScholarGate
Assistente

Confronta i metodi

Esamina i metodi selezionati fianco a fianco; le righe che differiscono sono evidenziate.

Studio multicentrico di Fase IV×Trial Clinico Randomizzato (RCT)×
CampoEpidemiologiaEpidemiologia
FamigliaProcess / pipelineProcess / pipeline
Anno di origine1980s–1990s (formalized with post-marketing requirements in modern drug regulation)1948 (first rigorously conducted RCT — MRC streptomycin trial)
IdeatoreRegulatory agencies and pharmaceutical industry (ICH E2E, FDA, EMA post-marketing frameworks)Austin Bradford Hill; MRC Streptomycin Trial team
TipoObservational or interventional post-marketing studyInterventional experimental study
Fonte seminaleStrom, B. L., & Kimmel, S. E. (Eds.). (2005). Textbook of Pharmacoepidemiology. John Wiley & Sons. ISBN: 978-0470029619Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015). Fundamentals of Clinical Trials (5th ed.). Springer. ISBN: 978-3319185385
Aliasmulticenter post-marketing study, multicenter pharmacovigilance study, multi-site phase IV study, post-authorization safety studyRCT, randomized controlled trial, randomised controlled trial, clinical randomized trial
Correlati66
SintesiA multicenter Phase IV study is a post-marketing surveillance investigation conducted simultaneously at two or more clinical or research sites after a drug, device, or intervention has received regulatory approval. By pooling real-world data from diverse patient populations and geographic regions, it detects rare adverse events, evaluates long-term effectiveness, characterizes safety in subgroups, and fulfills regulatory post-authorization commitments that single-site studies cannot achieve.A randomized clinical trial (RCT) is an experimental study design in which participants are randomly assigned to an intervention group or a control group, then followed prospectively to compare outcomes. Random allocation is the defining feature: it distributes known and unknown confounders across groups by chance, making the RCT the strongest individual study design for establishing causal efficacy of a treatment or intervention under controlled conditions.
ScholarGateInsieme di dati
  1. v1
  2. 2 Fonti
  3. PUBLISHED
  1. v1
  2. 2 Fonti
  3. PUBLISHED

Vai alla ricerca Scarica le diapositive

ScholarGateConfronta i metodi: Multicenter Phase IV Study · Randomized clinical trial. Consultato il 2026-06-18 da https://scholargate.app/it/compare